Vascular Imaging Market
Report ID: SQMIG35A3421
Report ID: SQMIG35A3421
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3421 |
Region:
Global |
Published Date: May, 2026
Pages:
157
|Tables:
126
|Figures:
77
Global Vascular Imaging Market size was valued at USD 2.3 Billion in 2024 and is poised to grow from USD 2.38 Billion in 2025 to USD 3.16 Billion by 2033, growing at a CAGR of 3.6% during the forecast period (2026-2033).
The primary driver of the vascular imaging market is the rising burden of cardiovascular and peripheral vascular disease among aging and lifestyle-affected populations, which increases demand for accurate diagnosis and image-guided therapy. Vascular imaging encompasses diagnostic modalities such as ultrasound, CT angiography, MR angiography and intravascular techniques like IVUS and OCT, and it matters because timely detection and precise characterization of lesions reduce morbidity and healthcare costs. Over several decades the field has evolved from conventional catheter angiography toward noninvasive cross-sectional methods and catheter-based intravascular imaging, for example widespread CT angiography for pulmonary embolism and IVUS-guided coronary interventions across regions.
Building on the transition to noninvasive and intravascular imaging, rapid technological innovation represents the key trend driving global vascular imaging sector growth because it enhances diagnostic precision. Advances such as high-resolution CT scanners, portable duplex ultrasound and AI-driven image analysis enable clinicians to detect stenoses earlier and plan endovascular repairs more accurately, which reduces procedure times and complication rates. In practice vascular surgeons rely on CT-based three-dimensional reconstructions to size stent grafts and interventional cardiologists use IVUS plus automated plaque quantification to guide stent placement. These capabilities expand reimbursement impetus and market penetration particularly in outpatient and emerging market settings.
How is AI Improving Diagnostic Accuracy in the Vascular Imaging Market?
AI is improving diagnostic accuracy in vascular imaging by combining automated image quality control with precise vessel segmentation and advanced feature extraction. Key aspects include standardized measurement workflows multimodal data fusion and radiomics that reveal subtle plaque and wall changes invisible to the eye. The current market shows wider adoption as vendors integrate AI driven analysis into ultrasound CT and MR systems to reduce reader variability and to prioritize urgent cases for faster review. Practical examples include automated aortic measurement tools and AI assisted plaque characterization that make reporting more consistent and help clinicians make clearer treatment decisions.
In April 2026, Viz.ai announced a partnership to bring AI powered detection and coordinated care to rural hospitals which supports market growth by expanding access to vascular imaging insights enabling earlier diagnosis and by streamlining referrals and specialist input to improve efficiency.
Market snapshot - (2026-2033)
Global Market Size
USD 2.3 Billion
Largest Segment
Ultrasound Imaging
Fastest Growth
Intravascular Imaging
Growth Rate
3.6% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global vascular imaging market is segmented by imaging modality, portability, application, end user and region. Based on imaging modality, the market is segmented into Ultrasound Imaging, Computed Tomography (CT) Imaging, Magnetic Resonance Imaging (MRI), X-ray Angiography & Fluoroscopy, Nuclear Imaging, Optical Imaging and Intravascular Imaging. Based on portability, the market is segmented into Fixed Systems and Mobile/Portable Systems. Based on application, the market is segmented into Coronary Artery Disease, Peripheral Vascular Disease, Neurovascular Disorders, Aortic Diseases, Venous Disorders, Oncology-Related Vascular Imaging and Others. Based on end user, the market is segmented into Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers (ASCs), Cardiology & Vascular Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Based on the global vascular imaging market growth, ultrasound imaging segment dominates because its noninvasive nature, affordability, and real time hemodynamic assessment make it the frontline modality for vascular evaluation across care settings. Broad-based familiarity among clinicians, ongoing advancements in Doppler and contrast-enhanced methodologies, and usability within point-of-care settings promote extensive utilization of the device. All of these features reduce barriers to diagnosis; provide more immediate information for clinicians at the bedside; and provide additional clinical uses, including venous mapping and peripheral artery assessment, reinforcing the device's leadership position within its category.
However, computed tomography (CT) imaging is witnessing the strongest growth momentum driven by advancements in high resolution angiographic protocols, faster scanner technologies, and improved image reconstruction that extend utility in complex aortic and neurovascular assessments. Expanding clinician confidence, enhanced pre procedural planning capabilities, and growing indications for noninvasive vascular mapping create new demand and open additional avenues for clinical integration and market opportunity.
Fixed systems segment dominates because they deliver the high performance imaging platforms necessary for complex vascular interventions and large volume diagnostic services. The connecting between catheterizing laboratories and imaging laboratories allows for advanced angiograms as well as high quality CT and MRI scans. There are connections that allow for multiple disciplines to work together and for the healthcare facility to be more efficient with workflows through technological integrations. The priorities of an institution's capital investment and a clinician's dependence on durable, high quality machines influence how much equipment is eventually purchased and how long will it continue to be used within the hospital facility.
Meanwhile, mobile/portable systems are the most rapidly expanding area as demand for point of care diagnostics and bedside vascular assessment grows alongside miniaturized ultrasound and mobile angiography solutions. Advances in device miniaturization, wireless connectivity, and telemedicine integration broaden access across ambulatory and procedural settings, enabling new care pathways, quicker triage, and expanded procurement opportunities for providers seeking flexible imaging capabilities.
To get detailed segments analysis, Request a Free Sample Report
Based on the global vascular imaging market share, North America leads due to concentration of advanced healthcare infrastructure, early technology adoption, large base of specialized clinicians, robust reimbursement frameworks, and strong presence of major manufacturers and research institutions. Innovation in imaging systems and software is fueled by high levels of clinical research and collaborative networks; therefore, centralized referral centres facilitate the introduction of complex vascular diagnostic tools. There are regulatory pathways that help improve the ability to gain access to novel devices, as well as, an iterative process to support their use in the marketplace. The demand for high-resolution multimodal vascular imaging is driven by health systems focusing on preventive cardiovascular care and minimally invasive interventions. There is substantial private capital being invested and payer involvement that supports the commercialization of this technology.
Vascular imaging market in United States is characterized by concentration of leading device manufacturers, extensive clinical trial activity, and integrated care networks that support adoption of advanced imaging modalities. Strong private investment and well-established reimbursement pathways encourage the commercialization of novel techniques. Academic medical centers and specialty practices need to work together on studies validating work and on training efforts that make clinicians feel comfortable. This allows imaging solutions to keep demand in hospitals and outpatient settings on a general scale.
Vascular imaging market in Canada benefits from a network of hospitals, health funding structures that facilitate procurement of diagnostic platforms, and collaborative research between universities and clinical centers. The drive for population screening and integrated vascular care pathways are leading greater utilization of non-invasive and minimally invasive imaging modalities. Local distributors of these modalities support the use of this technology in both hospitals and community-based healthcare settings while clinician training programs are improving clinician proficiency and overall integration of advanced imaging into diagnostic workflows.
Based on global vascular imaging regional forecast, Europe expansion is driven by a combination of strong clinical expertise, a mature medical device industry, and coordinated public health initiatives that prioritize cardiovascular outcomes. Through well-established hospital networks and specialized vascular centers, imaging technology diffusion occurs easily. In addition, harmonization of regional regulations facilitates cross-border adoption and market entry. Thirdly, through integrated diagnostics investment, prioritization of minimally invasive procedures, and collaboration between industry and academic networks, the development of imaging solutions specific to local markets can be expedited. Lastly, multiple procurement frameworks and tendering processes in various markets support large scale procurement of high resolution images. Additionally, the increase of clinician experience with new/high-tech modalities increases the demand for high resolution vascular imaging.
Vascular imaging market in Germany benefits from a strong medtech manufacturing base, specialized hospital networks, and clinical expertise that drive adoption of advanced imaging modalities. Industry and academic collaborations facilitate technology refinement and clinical validation. Procuring practices and clinical guidelines laid down assist in implementing all varieties of care provider sector thus serving as a regional hub for growth and validation for new technologies in the creation, assessment, and incorporation of new vascular imaging technology into complexity of care and long-term clinical investment.
Vascular imaging market in United Kingdom is experiencing accelerated adoption driven by strong clinical innovation, supportive policy frameworks, and active collaboration between industry and national health services. There is a need for more portable imaging platforms because of the demand for outpatient diagnostic tests and the use of less invasive methods in performing procedures. Investments in digital integration and imaging analytics can improve how clinicians work and increase acceptance by clinicians. Pilot programs and commercial implementations can create opportunities to implement more broadly in hospitals and community healthcare networks.
Vascular imaging market in France is evolving through targeted public procurement, strong academic research, and growing engagement from medical technology companies. Central healthcare systems facilitate the coordinated implementation of imaging technologies and pilot programs that demonstrate the value of these systems in providing clinical care. Throughout this process, clinical societies have supported the adoption of new technologies and developers of new technologies have been able to invest in image analysis and interoperability to ensure that systems can be integrated across different hospital affiliations.
As per global vascular imaging regional outlook, Asia Pacific is strengthening its role through focused investment in healthcare infrastructure, expansion of specialty care centers, and growing capabilities among regional device manufacturers. Regulatory frameworks are evolving to approach and streamline the approval process for the commercialization of imaging technologies, creating an increase in market maturity. The clinical expertise within the key markets and widespread adoption of Digital Health and Artificial Intelligence (AI)-enabled image analytics are contributing to the ability to provide better diagnostic services and workflows. Partnerships with international vendors and locally tailored strategies for technology transfer and scalable service models are being developed gradually as are long-term reimbursement policies and patient awareness of the benefit of using these technologies, ultimately supporting continued use in both urban and regional healthcare center settings.
Vascular imaging market in Japan is driven by a mature medtech ecosystem, strong manufacturers, and clinician expertise that favor adoption of advanced imaging systems. Precision diagnostics, along with using imaging together with intervention, has been a growing area of focus for both hospitals/centers of specialty care. This has increased the need for clarity surrounding regulations and greater collaboration between industry and academia, as well as the need for validating and optimizing products at local institutions. Investments to support clinical utilization and continual improvement of vascular imaging workflows will be made in imaging analytics and quality assurance.
Vascular imaging market in South Korea benefits from a dynamic medtech sector, manufacturing strengths, and early clinical adoption of innovative imaging technologies. Hospitals and clinics place a strong emphasis on the use of less stressful imaging techniques for patients and for getting advanced imaging used in the course of procedures. The collaboration between hospitals and private industry allows for faster testing/devices being used, and the emphasis on digital imaging and artificial intelligence increasing in importance as well as the use of digital means of enhancing image interpretation by both hospital systems throughout the U.S. overall.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Cardiovascular Disease Prevalence
Adoption Of Advanced Imaging Modalities
High Equipment And Operational Costs
Limited Reimbursement And Regulatory Hurdles
Request Free Customization of this report to help us to meet your business objectives.
Competition in global vascular imaging market outlook is intensifying as imaging OEMs, AI specialists, and robotics firms converge to offer integrated diagnostic and intervention solutions, competition is being driven by demand for operator independent imaging, faster bedside decision support, and end to end therapy workflows. Notable strategic moves include Siemens Healthineers acquisition of Corindus to add robotic vascular intervention capability, GE HealthCare partnerships with NVIDIA to accelerate AI inference in imaging platforms, and Butterfly Network launching the BiQ3 handheld ultrasound to extend portable vascular visualization.
Top Player’s Company Profile
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global vascular imaging industry is primarily driven by the rising prevalence of cardiovascular and peripheral vascular diseases, with a second strong driver coming from rapid technological innovation including AI-enabled analytics and portable imaging solutions. Ultrasound imaging remains the dominating segment due to its noninvasive, affordable, and bedside capabilities, while North America is the dominating region given advanced infrastructure, reimbursement support, and concentrated R&D. Market expansion is tempered by high equipment and operational costs that limit adoption in resource constrained settings. Overall, demand for precise, faster vascular diagnostics and image guided therapy continues to propel investment and clinical adoption worldwide.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 2.3 Billion |
| Market size value in 2033 | USD 3.16 Billion |
| Growth Rate | 3.6% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Vascular Imaging Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Vascular Imaging Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Vascular Imaging Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Vascular Imaging Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Vascular Imaging Market size was valued at USD 2.3 Billion in 2024 and is poised to grow from USD 2.38 Billion in 2025 to USD 3.16 Billion by 2033, growing at a CAGR of 3.6% during the forecast period (2026-2033).
Competition in global vascular imaging is intensifying as imaging OEMs, AI specialists, and robotics firms converge to offer integrated diagnostic and intervention solutions; competition is being driven by demand for operator independent imaging, faster bedside decision support, and end to end therapy workflows. Notable strategic moves include Siemens Healthineers acquisition of Corindus to add robotic vascular intervention capability, GE HealthCare partnerships with NVIDIA to accelerate AI inference in imaging platforms, and Butterfly Network launching the BiQ3 handheld ultrasound to extend portable vascular visualization. 'GE HealthCare', 'Siemens Healthineers', 'Philips Healthcare', 'Canon Medical Systems Corporation', 'FUJIFILM Holdings Corporation', 'Hologic, Inc.', 'Samsung Medison', 'Mindray Medical International Limited', 'Abbott Laboratories', 'Shimadzu Corporation', 'Carestream Health', 'Hitachi Medical Systems', 'AngioDynamics, Inc.', 'Pie Medical Imaging', 'Arterys', 'Terason', 'LeMaitre Vascular', 'BD', 'Koninklijke Philips N.V.', 'Esaote SpA'
The increasing prevalence of cardiovascular diseases drives demand for vascular imaging by expanding the pool of patients requiring diagnosis, monitoring, and intervention planning. As clinicians seek more accurate visualization of vascular anatomy and pathology, hospitals and imaging centers prioritize procurement and integration of vascular imaging solutions to improve diagnostic confidence and treatment outcomes. This sustained clinical need encourages investment in imaging infrastructure, training, and workflow optimization, thereby supporting market expansion through heightened utilization and continuous demand for both established and emerging imaging technologies.
Ai Enhanced Diagnostic Workflows: AI driven image analysis and workflow tools are accelerating diagnostic accuracy and consistency across vascular imaging modalities. Advanced algorithms assist in vessel segmentation, plaque characterization, and automated reporting, streamlining clinician workflows and enabling faster treatment planning. Integration with hospital information systems and cloud platforms supports collaborative review and continuous learning. As vendor solutions evolve to emphasize interpretive transparency and validation, adoption grows among radiologists and vascular specialists seeking reproducible assessments and decision support that complement rather than replace clinical expertise.
Why does North America Dominate the Global Vascular Imaging Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
